Pediatric Head Lice Study Product Comparison

Status Completed

Clinical Trial Summary

- To evaluate the efficacy of LiceMD for the treatment of head lice in a pediatric population.

- To evaluate the safety of LiceMD in a pediatric population.

Clinical Trial Description

Head lice, or Pediculus humanus capitis, cause an estimated 6 to 12 million infestations per year in the U.S., most commonly affecting children 3 to 11 years of age. Despite common perceptions, head lice crawl, and cannot hop or fly. For this reason, transmission occurs most often by human head-to-head contact, and much less commonly by the sharing of personal items such as hats, coats, combs, or towels. Because head lice feed on human blood, they cannot live on pets and are only viable 1-2 days on surfaces other than the human head. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Head Lice

Clinical Trial Details

NCT number	NCT02213055
Study type	Interventional
Source	Hackensack University Medical Center
Contact
Status	Completed
Phase	Phase 2
Start date	May 2009
Completion date	August 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00988533` - A Pharmacokinetics (PK) Study in Lice Infested Children 6 Months to 3 Years of Age	Phase 1
Completed	`NCT00672971` - Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice	N/A
Completed	`NCT00858481` - A Pilot Dose Ranging Study of Spinosad Creme Rinse	Phase 2
Completed	`NCT03301649` - Clinical Endpoint Study of Ivermectin 0.5% Lotion	Phase 3
Completed	`NCT00994422` - Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects	Phase 2
Completed	`NCT00995124` - Trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion®, NeutraLice Advance® and Moov Head Lice Solution®) After a Single Application	Phase 4
Completed	`NCT03337490` - A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice	Phase 3
Completed	`NCT06333054` - Safety and Efficacy of a Head Lice Shampoo	N/A
Completed	`NCT02974088` - Neem Lotion With Combing for Lice	Phase 2
Recruiting	`NCT05379114` - Comparative Study for the Evaluation of a New Medical Device on the Treatment of Head Lice Infestation	N/A
Completed	`NCT03617926` - A Clinical Trial to Evaluate Efficacy and Safety of a Water-soluble Head Lice Product.	N/A
Completed	`NCT01803581` - A Study to Evaluate the Safety and Efficacy of Product X92001327 vs RID Shampoo in Subjects With Head Lice	N/A
Completed	`NCT01066585` - A Safety and Efficacy Study Comparing 0.5% Ivermectin Cream to a Vehicle Control in Subjects With Head Lice Infestation	Phase 3
Completed	`NCT01068158` - A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects	Phase 3
Completed	`NCT00857935` - A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse	Phase 2
Completed	`NCT00301340` - Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice	Phase 3
Completed	`NCT02061813` - Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion	Phase 1
Completed	`NCT02062073` - Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion	Phase 1
Completed	`NCT00605956` - NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers	Phase 1
Completed	`NCT00479310` - Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice	Phase 3